Transasia donates 5 lakh tablets for COVID-19 treatment

Transasia Bio-Medicals has donated over five lakh tablets worth more than Rs 50 lakhs for COVID-19 patients. The medicines are from reputed pharmaceutical manufacturers and come with a long-dated shelf life of up to 2023. The procurement and distribution of the medicines have been executed by the Vazirani Foundation, the CSR arm of Transasia Bio-Medicals and closely coordinated by Transasia’s team of over 700 on-field personnel along with various charitable trusts.

Mala Vazirani, Executive Director, Transasia Bio-Medicals said, “In our endeavour to make quality healthcare available to the needy and underprivileged, we are partnering with NGOs and mission hospitals to fight against this disease and are quickly working to mobilize the largest humanitarian relief effort in our company’s history.”